▶ 調査レポート

口唇ヘルペス治療・予防の世界市場(~2026年)

• 英文タイトル:Global Treatment and Prevention of Herpes Labialis Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。口唇ヘルペス治療・予防の世界市場(~2026年) / Global Treatment and Prevention of Herpes Labialis Market Size, Status and Forecast 2020-2026 / MRC2-11QY04899資料のイメージです。• レポートコード:MRC2-11QY04899
• 出版社/出版日:QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、129ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は口唇ヘルペス治療・予防のグローバル市場について調査・分析したレポートです。種類別(バラシクロビル、アシクロビル、ファムシクロビル、ドコサノール、その他)市場規模、用途別(外用、経口、注射)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別口唇ヘルペス治療・予防の競争状況、市場シェア
・世界の口唇ヘルペス治療・予防市場:種類別市場規模 2015年-2020年(バラシクロビル、アシクロビル、ファムシクロビル、ドコサノール、その他)
・世界の口唇ヘルペス治療・予防市場:種類別市場規模予測 2021年-2026年(バラシクロビル、アシクロビル、ファムシクロビル、ドコサノール、その他)
・世界の口唇ヘルペス治療・予防市場:用途別市場規模 2015年-2020年(外用、経口、注射)
・世界の口唇ヘルペス治療・予防市場:用途別市場規模予測 2021年-2026年(外用、経口、注射)
・北米の口唇ヘルペス治療・予防市場分析:米国、カナダ
・ヨーロッパの口唇ヘルペス治療・予防市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの口唇ヘルペス治療・予防市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の口唇ヘルペス治療・予防市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの口唇ヘルペス治療・予防市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):GSK、Novartis、Teva、Mylan、Cadila、Apotex、Daewoong Pharmaceutical、Livzon、Luoxin、Med shine、Bayer (Campho Phenique)、Blistex、Kelun Group、Hikma、Haiwang、Carmex、Cipher
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Treatment and Prevention of Herpes Labialis Market
The global Treatment and Prevention of Herpes Labialis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Treatment and Prevention of Herpes Labialis Scope and Market Size
Treatment and Prevention of Herpes Labialis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Treatment and Prevention of Herpes Labialis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
GSK
Novartis
Teva
Mylan
Cadila
Apotex
Daewoong Pharmaceutical
Livzon
Luoxin
Med shine
Bayer (Campho Phenique)
Blistex
Kelun Group
Hikma
Haiwang
Carmex
Cipher

Market segment by Type, the product can be split into
Valacyclovir
Aciclovir
Famciclovir
Docosanol
Other
Market segment by Application, split into
External Use
Oral
Injection

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Treatment and Prevention of Herpes Labialis Revenue
1.4 Market by Type
1.4.1 Global Treatment and Prevention of Herpes Labialis Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Valacyclovir
1.4.3 Aciclovir
1.4.4 Famciclovir
1.4.5 Docosanol
1.4.6 Other
1.5 Market by Application
1.5.1 Global Treatment and Prevention of Herpes Labialis Market Share by Application: 2020 VS 2026
1.5.2 External Use
1.5.3 Oral
1.5.4 Injection
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Treatment and Prevention of Herpes Labialis Market Perspective (2015-2026)
2.2 Global Treatment and Prevention of Herpes Labialis Growth Trends by Regions
2.2.1 Treatment and Prevention of Herpes Labialis Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Treatment and Prevention of Herpes Labialis Historic Market Share by Regions (2015-2020)
2.2.3 Treatment and Prevention of Herpes Labialis Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Treatment and Prevention of Herpes Labialis Market Growth Strategy
2.3.6 Primary Interviews with Key Treatment and Prevention of Herpes Labialis Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Treatment and Prevention of Herpes Labialis Players by Market Size
3.1.1 Global Top Treatment and Prevention of Herpes Labialis Players by Revenue (2015-2020)
3.1.2 Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Players (2015-2020)
3.1.3 Global Treatment and Prevention of Herpes Labialis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Treatment and Prevention of Herpes Labialis Market Concentration Ratio
3.2.1 Global Treatment and Prevention of Herpes Labialis Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Treatment and Prevention of Herpes Labialis Revenue in 2019
3.3 Treatment and Prevention of Herpes Labialis Key Players Head office and Area Served
3.4 Key Players Treatment and Prevention of Herpes Labialis Product Solution and Service
3.5 Date of Enter into Treatment and Prevention of Herpes Labialis Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Treatment and Prevention of Herpes Labialis Historic Market Size by Type (2015-2020)
4.2 Global Treatment and Prevention of Herpes Labialis Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Treatment and Prevention of Herpes Labialis Market Size by Application (2015-2020)
5.2 Global Treatment and Prevention of Herpes Labialis Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Treatment and Prevention of Herpes Labialis Market Size (2015-2020)
6.2 Treatment and Prevention of Herpes Labialis Key Players in North America (2019-2020)
6.3 North America Treatment and Prevention of Herpes Labialis Market Size by Type (2015-2020)
6.4 North America Treatment and Prevention of Herpes Labialis Market Size by Application (2015-2020)

7 Europe
7.1 Europe Treatment and Prevention of Herpes Labialis Market Size (2015-2020)
7.2 Treatment and Prevention of Herpes Labialis Key Players in Europe (2019-2020)
7.3 Europe Treatment and Prevention of Herpes Labialis Market Size by Type (2015-2020)
7.4 Europe Treatment and Prevention of Herpes Labialis Market Size by Application (2015-2020)

8 China
8.1 China Treatment and Prevention of Herpes Labialis Market Size (2015-2020)
8.2 Treatment and Prevention of Herpes Labialis Key Players in China (2019-2020)
8.3 China Treatment and Prevention of Herpes Labialis Market Size by Type (2015-2020)
8.4 China Treatment and Prevention of Herpes Labialis Market Size by Application (2015-2020)

9 Japan
9.1 Japan Treatment and Prevention of Herpes Labialis Market Size (2015-2020)
9.2 Treatment and Prevention of Herpes Labialis Key Players in Japan (2019-2020)
9.3 Japan Treatment and Prevention of Herpes Labialis Market Size by Type (2015-2020)
9.4 Japan Treatment and Prevention of Herpes Labialis Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Treatment and Prevention of Herpes Labialis Market Size (2015-2020)
10.2 Treatment and Prevention of Herpes Labialis Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Treatment and Prevention of Herpes Labialis Market Size by Type (2015-2020)
10.4 Southeast Asia Treatment and Prevention of Herpes Labialis Market Size by Application (2015-2020)

11 India
11.1 India Treatment and Prevention of Herpes Labialis Market Size (2015-2020)
11.2 Treatment and Prevention of Herpes Labialis Key Players in India (2019-2020)
11.3 India Treatment and Prevention of Herpes Labialis Market Size by Type (2015-2020)
11.4 India Treatment and Prevention of Herpes Labialis Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Treatment and Prevention of Herpes Labialis Market Size (2015-2020)
12.2 Treatment and Prevention of Herpes Labialis Key Players in Central & South America (2019-2020)
12.3 Central & South America Treatment and Prevention of Herpes Labialis Market Size by Type (2015-2020)
12.4 Central & South America Treatment and Prevention of Herpes Labialis Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 GSK
13.1.1 GSK Company Details
13.1.2 GSK Business Overview
13.1.3 GSK Treatment and Prevention of Herpes Labialis Introduction
13.1.4 GSK Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020))
13.1.5 GSK Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Treatment and Prevention of Herpes Labialis Introduction
13.2.4 Novartis Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Teva
13.3.1 Teva Company Details
13.3.2 Teva Business Overview
13.3.3 Teva Treatment and Prevention of Herpes Labialis Introduction
13.3.4 Teva Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020)
13.3.5 Teva Recent Development
13.4 Mylan
13.4.1 Mylan Company Details
13.4.2 Mylan Business Overview
13.4.3 Mylan Treatment and Prevention of Herpes Labialis Introduction
13.4.4 Mylan Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020)
13.4.5 Mylan Recent Development
13.5 Cadila
13.5.1 Cadila Company Details
13.5.2 Cadila Business Overview
13.5.3 Cadila Treatment and Prevention of Herpes Labialis Introduction
13.5.4 Cadila Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020)
13.5.5 Cadila Recent Development
13.6 Apotex
13.6.1 Apotex Company Details
13.6.2 Apotex Business Overview
13.6.3 Apotex Treatment and Prevention of Herpes Labialis Introduction
13.6.4 Apotex Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020)
13.6.5 Apotex Recent Development
13.7 Daewoong Pharmaceutical
13.7.1 Daewoong Pharmaceutical Company Details
13.7.2 Daewoong Pharmaceutical Business Overview
13.7.3 Daewoong Pharmaceutical Treatment and Prevention of Herpes Labialis Introduction
13.7.4 Daewoong Pharmaceutical Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020)
13.7.5 Daewoong Pharmaceutical Recent Development
13.8 Livzon
13.8.1 Livzon Company Details
13.8.2 Livzon Business Overview
13.8.3 Livzon Treatment and Prevention of Herpes Labialis Introduction
13.8.4 Livzon Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020)
13.8.5 Livzon Recent Development
13.9 Luoxin
13.9.1 Luoxin Company Details
13.9.2 Luoxin Business Overview
13.9.3 Luoxin Treatment and Prevention of Herpes Labialis Introduction
13.9.4 Luoxin Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020)
13.9.5 Luoxin Recent Development
13.10 Med shine
13.10.1 Med shine Company Details
13.10.2 Med shine Business Overview
13.10.3 Med shine Treatment and Prevention of Herpes Labialis Introduction
13.10.4 Med shine Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020)
13.10.5 Med shine Recent Development
13.11 Bayer (Campho Phenique)
10.11.1 Bayer (Campho Phenique) Company Details
10.11.2 Bayer (Campho Phenique) Business Overview
10.11.3 Bayer (Campho Phenique) Treatment and Prevention of Herpes Labialis Introduction
10.11.4 Bayer (Campho Phenique) Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020)
10.11.5 Bayer (Campho Phenique) Recent Development
13.12 Blistex
10.12.1 Blistex Company Details
10.12.2 Blistex Business Overview
10.12.3 Blistex Treatment and Prevention of Herpes Labialis Introduction
10.12.4 Blistex Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020)
10.12.5 Blistex Recent Development
13.13 Kelun Group
10.13.1 Kelun Group Company Details
10.13.2 Kelun Group Business Overview
10.13.3 Kelun Group Treatment and Prevention of Herpes Labialis Introduction
10.13.4 Kelun Group Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020)
10.13.5 Kelun Group Recent Development
13.14 Hikma
10.14.1 Hikma Company Details
10.14.2 Hikma Business Overview
10.14.3 Hikma Treatment and Prevention of Herpes Labialis Introduction
10.14.4 Hikma Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020)
10.14.5 Hikma Recent Development
13.15 Haiwang
10.15.1 Haiwang Company Details
10.15.2 Haiwang Business Overview
10.15.3 Haiwang Treatment and Prevention of Herpes Labialis Introduction
10.15.4 Haiwang Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020)
10.15.5 Haiwang Recent Development
13.16 Carmex
10.16.1 Carmex Company Details
10.16.2 Carmex Business Overview
10.16.3 Carmex Treatment and Prevention of Herpes Labialis Introduction
10.16.4 Carmex Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020)
10.16.5 Carmex Recent Development
13.17 Cipher
10.17.1 Cipher Company Details
10.17.2 Cipher Business Overview
10.17.3 Cipher Treatment and Prevention of Herpes Labialis Introduction
10.17.4 Cipher Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020)
10.17.5 Cipher Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Treatment and Prevention of Herpes Labialis Key Market Segments
Table 2. Key Players Covered: Ranking by Treatment and Prevention of Herpes Labialis Revenue
Table 3. Ranking of Global Top Treatment and Prevention of Herpes Labialis Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Treatment and Prevention of Herpes Labialis Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Valacyclovir
Table 6. Key Players of Aciclovir
Table 7. Key Players of Famciclovir
Table 8. Key Players of Docosanol
Table 9. Key Players of Other
Table 10. Global Treatment and Prevention of Herpes Labialis Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Treatment and Prevention of Herpes Labialis Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Treatment and Prevention of Herpes Labialis Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Treatment and Prevention of Herpes Labialis Market Share by Regions (2015-2020)
Table 14. Global Treatment and Prevention of Herpes Labialis Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Treatment and Prevention of Herpes Labialis Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Treatment and Prevention of Herpes Labialis Market Growth Strategy
Table 20. Main Points Interviewed from Key Treatment and Prevention of Herpes Labialis Players
Table 21. Global Treatment and Prevention of Herpes Labialis Revenue by Players (2015-2020) (Million US$)
Table 22. Global Treatment and Prevention of Herpes Labialis Market Share by Players (2015-2020)
Table 23. Global Top Treatment and Prevention of Herpes Labialis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Treatment and Prevention of Herpes Labialis as of 2019)
Table 24. Global Treatment and Prevention of Herpes Labialis by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Treatment and Prevention of Herpes Labialis Product Solution and Service
Table 27. Date of Enter into Treatment and Prevention of Herpes Labialis Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Treatment and Prevention of Herpes Labialis Market Size by Type (2015-2020) (Million US$)
Table 30. Global Treatment and Prevention of Herpes Labialis Market Size Share by Type (2015-2020)
Table 31. Global Treatment and Prevention of Herpes Labialis Revenue Market Share by Type (2021-2026)
Table 32. Global Treatment and Prevention of Herpes Labialis Market Size Share by Application (2015-2020)
Table 33. Global Treatment and Prevention of Herpes Labialis Market Size by Application (2015-2020) (Million US$)
Table 34. Global Treatment and Prevention of Herpes Labialis Market Size Share by Application (2021-2026)
Table 35. North America Key Players Treatment and Prevention of Herpes Labialis Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Treatment and Prevention of Herpes Labialis Market Share (2019-2020)
Table 37. North America Treatment and Prevention of Herpes Labialis Market Size by Type (2015-2020) (Million US$)
Table 38. North America Treatment and Prevention of Herpes Labialis Market Share by Type (2015-2020)
Table 39. North America Treatment and Prevention of Herpes Labialis Market Size by Application (2015-2020) (Million US$)
Table 40. North America Treatment and Prevention of Herpes Labialis Market Share by Application (2015-2020)
Table 41. Europe Key Players Treatment and Prevention of Herpes Labialis Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Treatment and Prevention of Herpes Labialis Market Share (2019-2020)
Table 43. Europe Treatment and Prevention of Herpes Labialis Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Treatment and Prevention of Herpes Labialis Market Share by Type (2015-2020)
Table 45. Europe Treatment and Prevention of Herpes Labialis Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Treatment and Prevention of Herpes Labialis Market Share by Application (2015-2020)
Table 47. China Key Players Treatment and Prevention of Herpes Labialis Revenue (2019-2020) (Million US$)
Table 48. China Key Players Treatment and Prevention of Herpes Labialis Market Share (2019-2020)
Table 49. China Treatment and Prevention of Herpes Labialis Market Size by Type (2015-2020) (Million US$)
Table 50. China Treatment and Prevention of Herpes Labialis Market Share by Type (2015-2020)
Table 51. China Treatment and Prevention of Herpes Labialis Market Size by Application (2015-2020) (Million US$)
Table 52. China Treatment and Prevention of Herpes Labialis Market Share by Application (2015-2020)
Table 53. Japan Key Players Treatment and Prevention of Herpes Labialis Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Treatment and Prevention of Herpes Labialis Market Share (2019-2020)
Table 55. Japan Treatment and Prevention of Herpes Labialis Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Treatment and Prevention of Herpes Labialis Market Share by Type (2015-2020)
Table 57. Japan Treatment and Prevention of Herpes Labialis Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Treatment and Prevention of Herpes Labialis Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Treatment and Prevention of Herpes Labialis Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Treatment and Prevention of Herpes Labialis Market Share (2019-2020)
Table 61. Southeast Asia Treatment and Prevention of Herpes Labialis Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Treatment and Prevention of Herpes Labialis Market Share by Type (2015-2020)
Table 63. Southeast Asia Treatment and Prevention of Herpes Labialis Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Treatment and Prevention of Herpes Labialis Market Share by Application (2015-2020)
Table 65. India Key Players Treatment and Prevention of Herpes Labialis Revenue (2019-2020) (Million US$)
Table 66. India Key Players Treatment and Prevention of Herpes Labialis Market Share (2019-2020)
Table 67. India Treatment and Prevention of Herpes Labialis Market Size by Type (2015-2020) (Million US$)
Table 68. India Treatment and Prevention of Herpes Labialis Market Share by Type (2015-2020)
Table 69. India Treatment and Prevention of Herpes Labialis Market Size by Application (2015-2020) (Million US$)
Table 70. India Treatment and Prevention of Herpes Labialis Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Treatment and Prevention of Herpes Labialis Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Treatment and Prevention of Herpes Labialis Market Share (2019-2020)
Table 73. Central & South America Treatment and Prevention of Herpes Labialis Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Treatment and Prevention of Herpes Labialis Market Share by Type (2015-2020)
Table 75. Central & South America Treatment and Prevention of Herpes Labialis Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Treatment and Prevention of Herpes Labialis Market Share by Application (2015-2020)
Table 77. GSK Company Details
Table 78. GSK Business Overview
Table 79. GSK Product
Table 80. GSK Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020) (Million US$)
Table 81. GSK Recent Development
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Product
Table 85. Novartis Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020) (Million US$)
Table 86. Novartis Recent Development
Table 87. Teva Company Details
Table 88. Teva Business Overview
Table 89. Teva Product
Table 90. Teva Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020) (Million US$)
Table 91. Teva Recent Development
Table 92. Mylan Company Details
Table 93. Mylan Business Overview
Table 94. Mylan Product
Table 95. Mylan Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020) (Million US$)
Table 96. Mylan Recent Development
Table 97. Cadila Company Details
Table 98. Cadila Business Overview
Table 99. Cadila Product
Table 100. Cadila Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020) (Million US$)
Table 101. Cadila Recent Development
Table 102. Apotex Company Details
Table 103. Apotex Business Overview
Table 104. Apotex Product
Table 105. Apotex Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020) (Million US$)
Table 106. Apotex Recent Development
Table 107. Daewoong Pharmaceutical Company Details
Table 108. Daewoong Pharmaceutical Business Overview
Table 109. Daewoong Pharmaceutical Product
Table 110. Daewoong Pharmaceutical Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020) (Million US$)
Table 111. Daewoong Pharmaceutical Recent Development
Table 112. Livzon Business Overview
Table 113. Livzon Product
Table 114. Livzon Company Details
Table 115. Livzon Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020) (Million US$)
Table 116. Livzon Recent Development
Table 117. Luoxin Company Details
Table 118. Luoxin Business Overview
Table 119. Luoxin Product
Table 120. Luoxin Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020) (Million US$)
Table 121. Luoxin Recent Development
Table 122. Med shine Company Details
Table 123. Med shine Business Overview
Table 124. Med shine Product
Table 125. Med shine Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020) (Million US$)
Table 126. Med shine Recent Development
Table 127. Bayer (Campho Phenique) Company Details
Table 128. Bayer (Campho Phenique) Business Overview
Table 129. Bayer (Campho Phenique) Product
Table 130. Bayer (Campho Phenique) Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020) (Million US$)
Table 131. Bayer (Campho Phenique) Recent Development
Table 132. Blistex Company Details
Table 133. Blistex Business Overview
Table 134. Blistex Product
Table 135. Blistex Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020) (Million US$)
Table 136. Blistex Recent Development
Table 137. Kelun Group Company Details
Table 138. Kelun Group Business Overview
Table 139. Kelun Group Product
Table 140. Kelun Group Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020) (Million US$)
Table 141. Kelun Group Recent Development
Table 142. Hikma Company Details
Table 143. Hikma Business Overview
Table 144. Hikma Product
Table 145. Hikma Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020) (Million US$)
Table 146. Hikma Recent Development
Table 147. Haiwang Company Details
Table 148. Haiwang Business Overview
Table 149. Haiwang Product
Table 150. Haiwang Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020) (Million US$)
Table 151. Haiwang Recent Development
Table 152. Carmex Company Details
Table 153. Carmex Business Overview
Table 154. Carmex Product
Table 155. Carmex Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020) (Million US$)
Table 156. Carmex Recent Development
Table 157. Cipher Company Details
Table 158. Cipher Business Overview
Table 159. Cipher Product
Table 160. Cipher Revenue in Treatment and Prevention of Herpes Labialis Business (2015-2020) (Million US$)
Table 161. Cipher Recent Development
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Treatment and Prevention of Herpes Labialis Market Share by Type: 2020 VS 2026
Figure 2. Valacyclovir Features
Figure 3. Aciclovir Features
Figure 4. Famciclovir Features
Figure 5. Docosanol Features
Figure 6. Other Features
Figure 7. Global Treatment and Prevention of Herpes Labialis Market Share by Application: 2020 VS 2026
Figure 8. External Use Case Studies
Figure 9. Oral Case Studies
Figure 10. Injection Case Studies
Figure 11. Treatment and Prevention of Herpes Labialis Report Years Considered
Figure 12. Global Treatment and Prevention of Herpes Labialis Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Treatment and Prevention of Herpes Labialis Market Share by Regions: 2020 VS 2026
Figure 14. Global Treatment and Prevention of Herpes Labialis Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Treatment and Prevention of Herpes Labialis Market Share by Players in 2019
Figure 17. Global Top Treatment and Prevention of Herpes Labialis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Treatment and Prevention of Herpes Labialis as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Treatment and Prevention of Herpes Labialis Revenue in 2019
Figure 19. North America Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Treatment and Prevention of Herpes Labialis Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed